Celldex Therapeutics, Inc. (NASDAQ:CLDX) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy […]
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine brokerages that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy […]
